Expression of CD203c on basophils as a marker of immunoglobulin E-mediated l-asparaginase allergy

Leukemia and Lymphoma

Volumn 55, Issue 1, 2014, Pages 92-96

  Hino, Moeko ^a   Shimojo, Naoki ^a   Ochiai, Hidemasa ^a   Inoue, Yuzaburo ^a   Ando, Kumiko ^a   Chikaraishi, Koji ^a   Ota, Setsuo ^b   Okimoto, Yuri ^c   Sunami, Shosuke ^d   Nakamura, Ryosuke ^e   Teshima, Reiko ^e   Sato, Yasunori ^f   Kohno, Yoichi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

^c CHIBA CHILDREN'S HOSPITAL   (Japan)

^d NARITA RED CROSS HOSPITAL   (Japan)

^e NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^f CHIBA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Basophil activation test; IgE mediated allergy; l asparaginase

Indexed keywords

ASPARAGINASE; CELL SURFACE MARKER; DEGRANULATION ACTIVATION MARKER CD203C; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG;

ADOLESCENT; ALLERGY TEST; ARTICLE; BASOPHIL; BASOPHIL ACTIVATION TEST; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; INFANT; LEUKOCYTE ACTIVATION; MALE; PREDICTIVE VALUE; PRESCHOOL CHILD; PRICK TEST; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SKIN TEST;

ADOLESCENT; ASPARAGINASE; BASOPHILS; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INFANT; LYMPHOMA; MALE; PHOSPHORIC DIESTER HYDROLASES; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PYROPHOSPHATASES; SENSITIVITY AND SPECIFICITY;

EID: 84891350115     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2013.794944     Document Type: Article

References (21)

1. Capizzi RL, Bertino JR, Skeel RT, et al. L-Asparaginase: Clinical, biochemical, pharmacological, and immunological studies. Ann Intern Med 1971; 74: 893-901.
2. Clavell LA, Gelber RD, Cohen HJ, et al. Four-Agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia. N Engl J. Med 1986; 315: 657-663.
3. Asselin BL, Ryan D, Frantz CN, et al. I n vitro and in vivo killing of acute lymphoblastic leukemia cells by L-Asparaginase. Cancer Res 1989; 49: 4363-4368.
4. Pui CH, Evans WE. Acute lymphoblastic leukemia. N Engl J. Med 1998; 339: 605-615.
5. Amylon MD, Shuster J, Pullen J, et al. Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: A Pediatric Oncology Group study. Leukemia 1999; 13: 335-342.
6. Oettgen HF, Stephenson PA, Schwartz MK, et al. Toxicity of E. coli L-Asparaginase in man. Cancer 1970; 25: 253-278.
7. Evans WE, Tsiatis A, Rivera G, et al. Anaphylactoid reactions to Escherichia coli and Erwinia asparaginase in children with leukemia and lymphoma. Cancer 1982; 49: 1378-1383.
8. Salzer W, Seibel N, Smith M. Erwinia asparaginase in pediatric acute lymphoblastic leukemia. Expert Opin Biol Th er 2012; 12: 1407-1414.
9. Cheung NK, Chau IY, Coccia PF. Antibody response to Escherichia coli L-Asparaginase. Prognostic significance and clinical utility of antibody measurement. Am J. Pediatr Hematol Oncol 1986; 8: 99-104.
10. Woo MH, Hak LJ, Storm MC, et al. Anti-Asparaginase antibodies following E coli asparaginase therapy in pediatric acute lymphoblastic leukemia. Leukemia 1998; 12: 1527-1533.
11. Liu C, Kawedia JD, Cheng C, et al. Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemia. Leukemia 2012; 26: 2303-2309.
12. Liccardi G, D'Amato G, Canonica GW, et al. Systemic reactions from skin testing: Literature review. J. Investig Allergol Clin Immunol 2006; 16: 75-78.
13. Hamilton RG, Franklin Adkinson N Jr. In vitro assays for the diagnosis of IgE-mediated disorders. J. Allergy Clin Immunol 2004; 114: 213-225; quiz 226.
14. Shreffler WG. E valuation of basophil activation in food allergy: Present and future applications. Curr Opin Allergy Clin Immunol 2006; 6: 226-233.
15. Manabe A, Ohara A, Hasegawa D, et al. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: The Tokyo Children's Cancer Study Group Study L99-15. Haematologica 2008; 93: 1155-1160.
16. Moricke A, Reiter A, Zimmermann M, et al. Risk-Adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: Treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood 2008; 111: 4477-4489.
17. Woo MH, Hak LJ, Storm MC, et al. Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemia. J. Clin Oncol 2000; 18: 1525-1532.
18. Killander D, Dohlwitz A, Engstedt L, et al. Hypersensitive reactions and antibody formation during L-Asparaginase treatment of children and adults with acute leukemia. Cancer 1976; 37: 220-228.
19. Nakamura R, Uchida Y, Higuchi M, et al. A convenient and sensitive allergy test: IgE crosslinking-induced luciferase expression in cultured mast cells. Allergy 2010; 65: 1266-1273.
20. Morell A, Terry WD, Waldmann T A. Metabolic properties of IgG subclasses in man. J. Clin Invest 1970; 49: 673-680.
21. Stone KD, Prussin C, Metcalf DD. IgE, mast cells, basophils, and eosinophils. J. Allergy Clin Immunol 2010; 125(Suppl. 2): S73-S80.